Trial
NCT03395873
Avelumab With Decitabine as First Line for AML Treatment of Patients With AML, Who Are Unfit for Intensive Chemotherapy
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Milton S. Hershey Medical Center
Collaborators
Pfizer
Condition
Acute Myeloid Leukemia
Intervention
Avelumab
Why stopped
Recent FDA approval of a new drug for the same patient population
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-21